They provided evidence that this MS-associated SNP might alter Drosha cleavage activity, thus modifying CD58 and microRNA-548ac gene expression in immune cells, a change that has already been reported to be relevant for MS development [53,54,55]. This evidence concerns the gene DROSHA and myeloid sarcoma.